Literature DB >> 21034200

Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study.

Barbara Hasse1, Bruno Ledergerber, Bernard Hirschel, Pietro Vernazza, Tracy R Glass, Andre Jeannin, John-Marc Evison, Luigia Elzi, Matthias Cavassini, Enos Bernasconi, Dunja Nicca, Rainer Weber.   

Abstract

BACKGROUND: Access to antiretroviral therapy may have changed condom use behavior. In January 2008, recommendations on condom use for human immunodeficiency virus (HIV)-positive persons were published in Switzerland, which allowed for unprotected sex under well-defined circumstances ("Swiss statement"). We studied the frequency, changes over time, and determinants of unprotected sex among HIV-positive persons.
METHODS: Self-reported information on sexual preference, sexual partners, and condom use was collected at semi-annual visits in all participants of the prospective Swiss HIV Cohort Study from April 2007 through March 2009. Multivariable logistic regression models were fit using generalized estimating equations to investigate associations between characteristics of cohort participants and condom use.
FINDINGS: A total of 7309 participants contributed to 21,978 visits. A total of 4291 persons (80%) reported sexual contacts with stable partners, 1646 (30%) with occasional partners, and 557 (10%) with stable and occasional partners. Of the study participants, 5838 (79.9%) of 7309 were receiving antiretroviral therapy, and of these, 4816 patients (82%) had a suppressed viral load. Condom use varied widely and differed by type of partner (visits with stable partners, 10,368 [80%] of 12,983; visits with occasional partners, 4300 [88%] of 4880) and by serostatus of stable partner (visits with HIV-negative partners, 7105 [89%] of 8174; visits with HIV-positive partners, 1453 [48%] of 2999). Participants were more likely to report unprotected sex with stable partners if they were receiving antiretroviral therapy, if HIV replication was suppressed, and after the publication of the "Swiss statement." Noninjection drug use and moderate or severe alcohol use were associated with unprotected sex.
CONCLUSIONS: Antiretroviral treatment and plasma HIV RNA titers influence sexual behavior of HIV-positive persons. Noninjection illicit drug and alcohol use are important risk factors for unprotected sexual contacts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034200     DOI: 10.1086/656809

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.

Authors:  Sophie Patterson; Angela Kaida; Paul Nguyen; Sabina Dobrer; Gina Ogilvie; Robert Hogg; Thomas Kerr; Julio Montaner; Evan Wood; M-J Milloy
Journal:  CMAJ Open       Date:  2016-04-28

Review 2.  Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature.

Authors:  Jennifer L Brown; Kelly S DeMartini; Jessica M Sales; Andrea L Swartzendruber; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

3.  Sexual HIV transmission and antiretroviral therapy: a prospective cohort study of behavioral risk factors among men and women living with HIV/AIDS.

Authors:  Seth C Kalichman; Chauncey Cherry; Denise White; Miche'l Jones; Tamar Grebler; Moira O Kalichman; Mervi Detorio; Angela M Caliendo; Raymond F Schinazi
Journal:  Ann Behav Med       Date:  2011-08

4.  HIV-transmission-related risk behavior in HIV+ African American men: Exploring biological, psychological, cognitive, and social factors.

Authors:  Alyssa Arentoft; Kathleen Van Dyk; April D Thames; Nicholas S Thaler; Philip Sayegh; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-06-28

5.  HIV/STI prevalence study among military conscripts in Estonia.

Authors:  R David Parker; Michael Regier; Joseph Widmeyer; Kristi Rüütel
Journal:  J Community Health       Date:  2015-04

6.  Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services.

Authors:  Brian T Montague; Christopher W Kahler; Suzanne M Colby; R Kathryn McHugh; Daniel Squires; Brianne Fitzgerald; Don Operario; Donna Gallagher; Peter M Monti; Kenneth H Mayer
Journal:  Addict Disord Their Treat       Date:  2015-03

Review 7.  HIV-1 treatment as prevention: the good, the bad, and the challenges.

Authors:  Kumi Smith; Kimberly A Powers; Angela D M Kashuba; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2011-07       Impact factor: 4.283

Review 8.  Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009-2012) in an era of treatment as prevention.

Authors:  Yiyun Chen
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

Review 9.  Antiviral agents and HIV prevention: controversies, conflicts, and consensus.

Authors:  Myron S Cohen; Kathryn E Muessig; M Kumi Smith; Kimberly A Powers; Angela D M Kashuba
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

Review 10.  HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.

Authors:  Marianne Martinello; Behzad Hajarizadeh; Jason Grebely; Gregory J Dore; Gail V Matthews
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.